KOREA PHARMA CO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 032300 for the last quarter is 19.83 B KRW, and it's 2.22% lower compared to the previous quarter. The net income of Q2 24 is 1.17 B KRW.